SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-002775
Filing Date
2023-01-10
Accepted
2023-01-10 16:14:16
Documents
2
Period of Report
2023-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 14922
2 POA DOCUMENT poa.txt EX-24 3475
  Complete submission text file 0001209191-23-002775.txt   19775
Mailing Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080 415-582-4923
Nkarta, Inc. (Issuer) CIK: 0001787400 (see all company filings)

IRS No.: 474515206 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6000 SHORELINE COURT, SUITE 102 SOUTH SAN FRANCISCO CA 94080
Business Address
Shook David (Reporting) CIK: 0001959742 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39370 | Film No.: 23521293